Long-term effects of hormone replacement therapy on bone mineral density in girls oophorectomized in adolescence

Gynecologic and Obstetric Investigation

Volumn 55, Issue 3, 2003, Pages 168-172

  Kanaoka, Y ^a   Honda, K ^a   Ishiko, O ^a   Hirai, K ^a   Ogita, S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone mineral density; Oophorectomy; Ovarian cancer; Puberty; Quality of life

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; MESTRANOL; NORETHISTERONE ACETATE;

ADOLESCENCE; ADOLESCENT; ADVANCED CANCER; ARTICLE; BONE DENSITY; BONE MINERAL; CANCER PATIENT; CASE REPORT; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; OUTCOMES RESEARCH; OVARIECTOMY; OVARY CANCER; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; PUBERTY; RECORDING; SEXUAL MATURITY;

BODY HEIGHT; BONE DENSITY; BREAST; CHILD; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR NECK; GENITALIA, FEMALE; HUMANS; LUMBAR VERTEBRAE; OVARIAN NEOPLASMS; OVARIECTOMY; PUBERTY;

EID: 0042744023     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071532     Document Type: Article

References (12)

1. Burger CW, van Leeuwen FE, Scheeele F, Kenemans P: Hormone replacement therapy in women treated for gynecological malignancy. Maturitas 1999;32:69-76.
2. Raber SA: The dense metaphyseal band sign. Radiology 1999;211:773-774.
3. Novak's Gynecology, ed 12. Baltimore, Williams & Wilkins, 1996, pp 772-776.
4. Turner RT, Riggs BL, Spelsberg TC: Skeletal effects of estrogen. Endocr Rev 1994;5:273-300.
5. Aiseberg J, Hsieh K, Kalaitzoglou G, Whittam E, Heller G, Schneider R, Sklar C: Bone mineral density in young adult survivors of childhood cancer. J Pediat Hematol Oncol 1998;20:241-245.
6. Mora S, Weber G, Guarneri MP, Nizzoli G, Pasolini D, Chiumello G: Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome. Obstet Gynecol 1992;79:747-751.
7. Prior JC: Progesterone as a bone trophic hormone. Endocr Rev 1990;11:386-398.
8. Adachi JD, Sargeant EJ, Sagle MA, Lamont D, Fawcett PD, Benson WG, McQueen M, Nazir DJ, Goldsmith CH: A double-blind randomized controlled trial of the effects of medroxy-progesterone acetate on bone density of women taking oestrogen replacement therapy. Br J Obstet Gynaecol 1997;104:64-70.
9. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endcrinol Metab 1991;73:555-563.
10. Creatsas G, Arefetz N, Adamopoulos PN, Konstantellou E, Aravantinos D: Transdermal estradiol plus oral medroxyprogesterone acetate replacement therapy in primary amenorrheic adolescents. Clinical, hormonal and metabolic aspects. Maturitas 1994;18:105-114.
11. Emans SJ, Grace E, Hoffer FA, Gunberg C, Ravnikar V, Woods E: Estrogen deficiency in adolescents and young adults: Impact on bone mineral content and effects of estrogen replacement therapy. Obstet Gynecol 1990;76:585-592.
12. Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF: Malignant germ cell tumors of ovary. Obstet Gynecol 2000;95:128-133.